Medical artificial intelligence (AI) solution development company VUNO gained the Class IIa CE markings for five of their AI solutions.

June 24, 2020 — Medical artificial intelligence (AI) solution development company VUNO gained the Class IIa CE markings for five of their AI solutions.

The five CE marked solutions are: VUNO Med-BoneAge, VUNO Med-DeepBrain, VUNO Med-Chest X-Ray, VUNO Med–Fundus AI and VUNO Med–LungCT AI. These products can now be commercialized and sold in 27 member states of the European Union, the Acceding countries as well as EFTA states. They can also make inroads into countries that recognize the European CE mark such as those in the Middle East, Asia, South and Central America, and Africa.

VUNO was assessed and deemed to meet EU safety and health protection requirements by a Notified Body based on a more stringent clinical validation standards and medical device guidelines. The efficacy and safety of those products demonstrated by a series of clinical research results and papers published in high impact journals and prestigious international seminars were of great help to satisfy the strict requirements.

Of the five MFDS (Ministry of Food and Drug Safety) approved products, four products (VUNO Med-Fundus AI, VUNO Med-Chest X-ray, and VUNO Med - BoneAge and VUNO Med Lung CT AI) received regulatory approval based on the proven effectiveness of performance through clinical trials. With such a robust portfolio, it is anticipated that VUNO Med solutions are to be used as key diagnostic supporting tools across many different medical environments overseas.

Hyun-Jun Kim, CEO of VUNO explained that, "We have been taking proper measures to ensure that VUNO's products obtain classification commensurate with their intended purposes as medical diagnostic supporting tools". He also added that, "In this sense, obtaining CE certification for all five products holds a great significance, and this will be able to accelerate our push for much anticipated global supply of VUNO Med series all around the world."

VUNO has been graining great traction at home and abroad with more than 100 active users of hospitals in Korea alone and is ready to deploy the CE marked products to international business partners and clients across different markets.

For more information: www.vuno.co


Related Content

News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Computed Tomography (CT)

Sept. 17, 2026 — Royal Philips and Southwest Mississippi Regional Medical Center (SMRMC), which serves as the hub of ...

Time September 24, 2026
arrow
News | RSNA

Sept. 22, 2026 — The Radiological Society of North America (RSNA) is now offering a certificate program that equips ...

Time September 24, 2026
arrow
News | Ultrasound Imaging

Sept. 16, 2026 — Ultrasound AI, Inc., a developer of artificial intelligence for medical imaging with a focus on ...

Time September 17, 2026
arrow
News | Radiology Education

Sept. 16, 2026 — As urgent care centers and outpatient healthcare facilities expand their use of diagnostic imaging, the ...

Time September 17, 2026
arrow
News | CT Angiography (CTA)

Sept. 15, 2026 — A new study published in the Journal of the American College of Radiology (JACR) found that an ...

Time September 15, 2026
arrow
News | PET Imaging

Sept. 10, 2026 — Siemens Healthineers Molecular Imaging has completed a $43.6 million construction and renovation ...

Time September 14, 2026
arrow
News | Breast Imaging

Sept. 10, 2026 — An artificial intelligence model that analyzes women's past and recent annual 3D mammograms is more ...

Time September 10, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

A radiologist pulls up a chest CT scan flagged for a pulmonary nodule. One artificial intelligence (AI) tool writes its ...

Time September 09, 2026
arrow
News | Lung Imaging

Sept. 8, 2026 – Brainomix and Endeavor BioMedicines recently presented positive results from the Brainomix AI-driven ...

Time September 09, 2026
arrow
Subscribe Now